 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
BAYER ANIMAL HEALTH SELLS ITS EQUINE PRODUCTS TO MERIAL
Dec. 22, 2014
Source: Bayer news release
Bayer HealthCare has entered into a definitive agreement to sell its equine products Legend®/Hyonate® (hyaluronate sodium) and Marquis® (ponazuril) to Merial, Inc. The deal is expected to close in the first quarter 2015 subject to customary conditions, including relevant merger control clearance.
"This transaction will allow our business to focus on innovation and growth in core segments for both companion and farm animals," said Dr. Dirk Ehle, Head of Bayer HealthCare's Animal Health Division. "These equine products have no strategic relevance for our business and represent less than 2 percent of our worldwide sales."
Hyaluronate sodium, marketed worldwide for over two decades as Legend® or Hyonate®, is an injectable solution that treats noninfectious joint dysfunction in horses.
Marquis® (ponazuril) Antiprotozoal Oral Paste, marketed in North America for over a decade, treats equine protozoal myeloencephalitis (EPM) - a disease that affects the central nervous system in horses.
|
|
|
|
|
